VR-PHO: Virtual Reality on Pain, Fear, and Emotional Appearance During Phlebotomy in Pediatric Hematology and Oncology Patients

Sponsor
Dokuz Eylul University (Other)
Overall Status
Completed
CT.gov ID
NCT05675358
Collaborator
Afyonkarahisar Health Sciences University (Other)
69
2
2
6
34.5
5.7

Study Details

Study Description

Brief Summary

In this study, the effect of virtual reality, which is one of the pain relief methods, on the pain, fear and emotional appearance associated with the procedure, was evaluated in children aged 4-12 years who will undergo phelobotomy in a Pediatric Hematology and Oncology outpatient clinic.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Virtual Reality
N/A

Detailed Description

This prospective randomized controlled study was conducted in the pediatric hematology and oncology polyclinic blood collection unit of a university hospital in Turkey.

Patients undergoing phelobotomy were allocated to virtual reality or control groups according to a stratified randomization scheme.

Study Design

Study Type:
Interventional
Actual Enrollment :
69 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
The child's pain and fear were evaluated blindly to each other by the parent and the nurse who performed the phelobotomy attempt.
Primary Purpose:
Supportive Care
Official Title:
Virtual Reality on Pain, Fear, and Emotional Appearance During Phlebotomy in Pediatric Hematology and Oncology Patients
Actual Study Start Date :
Mar 3, 2022
Actual Primary Completion Date :
Aug 3, 2022
Actual Study Completion Date :
Sep 3, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: virtual reality

In the study, Oculus Quest 2 256 GB All-In-One Vr Virtual Reality Glasses were used, and the Epic Roller Coasters train game, an application that would attract the attention of children, was determined by the researchers. The virtual reality application was started 2 minutes before the procedure and continued until the procedure was completed.

Behavioral: Virtual Reality
Oculus Quest 2 256 GB All-In-One Vr Virtual Reality Glasses were used in the study.

No Intervention: control

The child in the control group did not receive any additional intervention.

Outcome Measures

Primary Outcome Measures

  1. Pain assesed by Wong-Baker FACES [procedure - during the phelobotomy]

    Wong-Baker FACES (WB-FACES) Pain Rating Scale used. This scale uses in children aged 3 and older to rate pain severity. This numeric rating scale ranges from 0 to 10

  2. Fear assesed by Child Fear Scale [procedure -during the phelobotomy]

    The Child Fear Scale (CFS), this one-item scale measures procedure-related fear in children, consists of five sex-neutral faces, ranges from 0 (no fear) to extreme fear.

  3. Anxiety assesed by Children Anxiety Meter-State [procedure- during the phelobotomy]

    The Children's Anxiety Meter (CAM-S). The Children's Anxiety Meter assesses children's anxiety and uses before medical procedures. This scale is drawn like a thermometer with a bulb at the bottom and also includes horizontal lines at intervals going up to the top (0-10).

Secondary Outcome Measures

  1. emotional apperance assesed by Emotional Appearance Scale for Children [Baseline - before the phelobotomy]

    This scale allows direct behavioral observation, consists of 5 different behavioral categories; 'Facial Expression', 'Speaking', 'Activity', 'Interaction' and 'Cooperation Level'. Scale scoring is done by reviewing the descriptions of behavior in each category and selecting the numerical value that most represents the observed behavior. Each category is scored from 1 to 5.

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

the age range is between 4-12

to apply to the pediatric hematology and oncology outpatient clinic and to have blood taken

consent of the child and parent to voluntarily participate in the study

The child does not have a physical or psychological deficit that would prevent them from wearing glasses to watch virtual reality.

Exclusion Criteria:

having a fever (>37.5C) and severe dehydration

Before the invasive procedure, the patient was given anagesics.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Gülçin Özalp Gerçeker İzmir Turkey 35100
2 Gülçin Özalp Gerçeker İzmir Turkey

Sponsors and Collaborators

  • Dokuz Eylul University
  • Afyonkarahisar Health Sciences University

Investigators

  • Principal Investigator: Gülçin Özalp Gerçeker, pHD, RN, Dokuz Eylul University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gülçin Özalp Gerçeker, pHD, Assoc. Prof., Dokuz Eylul University
ClinicalTrials.gov Identifier:
NCT05675358
Other Study ID Numbers:
  • ASBU 2022/89
First Posted:
Jan 9, 2023
Last Update Posted:
Jan 9, 2023
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gülçin Özalp Gerçeker, pHD, Assoc. Prof., Dokuz Eylul University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 9, 2023